QAGE² Pharma Growth helps pharmaceutical, biotechnology, CRO/CDMO, medical-affairs and translational-research teams turn complex exploratory work into clear, reviewable positioning, campaign plans and institutional-pilot briefs.

• Free Q-PGA access through 15 July 2026 at 23:59 Singapore time.
• US$10 one-time founding access from 16 July 2026 at 00:00 Singapore time.
• No subscription or automatic renewal.
• The public research explorer remains free.

• QAGE² research-module previews covering AQDE, AQGRE, BBB/SOKS, mRNA concepts, oncology research and quantum-theory workflows.
• Q-PGA campaign-agent briefs for positioning, permission-led email, social posts, evidence workshops and 30-day launch plans.
• A first-pass scanner for risky clinical, comparative, regulatory, safety and absolute claims.
• Human-review checkpoints for medical, legal, regulatory, privacy and brand approval.
• Institutional-pilot planning for governed private deployment.

• Pharmaceutical R&D and translational science
• Medical affairs and scientific communications
• Commercial strategy and market access
• Digital innovation and responsible-AI programmes
• Biotech business development
• CRO/CDMO innovation and partnerships
• Academic and public research organisations

This public implementation is a research and marketing-workflow prototype. It is not a medical device, diagnostic service, clinical decision-support system or substitute for medical, legal or regulatory advice. Do not submit patient-identifiable information, protected health information, confidential trial data, private contact databases, credentials or payment-card details.

The agent drafts locally in the browser. It does not scrape contacts, autonomously send outreach or publish unsupported claims. Accountable human review is required before external use.

• Live platform: QAGE² Pharma Growth
• Shareable launch page: QAGE² public launch
• Campaign assets: public and permission-led launch copy
• Campaign framework: 60-day permission-led campaign playbook
• Payment integration: one-time checkout setup
• Security boundary: responsible-use and security notes

Translate complex exploratory biomedical workflows into evidence-aware, human-reviewable market conversations—without turning research outputs into unsupported clinical claims.

pharmaceutical-marketing · medical-affairs · biotech · responsible-ai · research-software · marketing-agents · github-pages